Eucrisa is a brand-name form of the generic medication crisaborole. Doctors prescribe it in topical form to help manage mild to moderate eczema. It belongs to a drug class called phosphodiesterase 4 (PDE4) inhibitors.
Eczema, or atopic dermatitis, is a skin condition involving inflammation that leads to cracked, dry, itchy skin. Eucrisa and other PDE4 inhibitors work by slowing and stopping the action of an enzyme called phosphodiesterase 4, which is involved in your body’s inflammatory response.
Stopping this enzyme’s action helps regulate inflammation in your skin, which can reduce some key eczema symptoms, including discoloration, pain, itchiness, and dryness.
Topical steroids are eczema’s
Steroid medications can have severe side effects, so doctors don’t often recommend them for long-term use. On the other hand, Eucrisa is generally tolerable with only mild to moderate side effects. It may be better for long-term treatment than steroid alternatives, and it may be better for use on more sensitive skin, like your eyelids.
Eucrisa is an ointment with a strength of 2%. You apply a thin layer twice per day, then once per day after you see favorable results. Experts generally consider the medication safe and effective in managing eczema, with its main side effect being pain or burning at the application site.
If you have eczema, contact a healthcare professional for diagnosis and treatment. They can evaluate your situation and prescribe the appropriate treatment. If you have any questions about Eucrisa, they can advise you.
Disclaimer: Healthline has made every effort to make certain that all information is factually correct, comprehensive, and up to date. However, this article should not be used as a substitute for the knowledge and expertise of a licensed healthcare professional. You should always consult your doctor or another healthcare professional before taking any medication. The drug information contained herein is subject to change and is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. The absence of warnings or other information for a given drug does not indicate that the drug or drug combination is safe, effective, or appropriate for all patients or all specific uses.



